author-photo

T. Newsom-Davis

Chelsea and Westminster Hospital NHS Foundation Trust

6

Papers

16

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

30-day mortality following initiation of immunotherapy for advanced stage lung cancer

2018 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (2)
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study

2017 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Resource Use and Associated Costs of Managing Docetaxel-Related Neutropenic Sepsis in Patients with Advanced Non-Small Cell Lung Cancer in The UK Nhs: Reveal-Ns

2017 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
87: Resource use associated with the management of docetaxel-related haematological toxicities, including neutropenic sepsis (NS), in patients with advanced non-small cell lung cancer (NSCLC) in the UK NHS: REVEAL-NS

2017 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
86: The rate of neutropenic sepsis (NS) and other haematological toxicities in patients with advanced non-small cell lung cancer (NSCLC) treated with docetaxel in the UK NHS: REVEAL-NS

2017 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Novel cancer therapies: treatments driven by tumour biology

2013 Postgraduate Medical Journal
Show All
- Source
- Cite
- Save
Citations (13)